nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—arteriole—metabolic syndrome X	0.187	0.305	CbGeAlD
Remoxipride—HTR2A—sympathetic nervous system—metabolic syndrome X	0.119	0.194	CbGeAlD
Remoxipride—HTR2A—autonomic nervous system—metabolic syndrome X	0.0799	0.13	CbGeAlD
Remoxipride—HTR2A—artery—metabolic syndrome X	0.0453	0.074	CbGeAlD
Remoxipride—HTR2A—endothelium—metabolic syndrome X	0.0383	0.0625	CbGeAlD
Remoxipride—HTR2A—blood vessel—metabolic syndrome X	0.0353	0.0576	CbGeAlD
Remoxipride—SIGMAR1—adipose tissue—metabolic syndrome X	0.0261	0.0426	CbGeAlD
Remoxipride—SIGMAR1—liver—metabolic syndrome X	0.0183	0.0298	CbGeAlD
Remoxipride—HTR2A—cardiovascular system—metabolic syndrome X	0.0158	0.0257	CbGeAlD
Remoxipride—HTR2A—kidney—metabolic syndrome X	0.0154	0.0252	CbGeAlD
Remoxipride—CYP2D6—kidney—metabolic syndrome X	0.014	0.0229	CbGeAlD
Remoxipride—HTR2A—liver—metabolic syndrome X	0.00974	0.0159	CbGeAlD
Remoxipride—CYP2D6—liver—metabolic syndrome X	0.00887	0.0145	CbGeAlD
Remoxipride—DRD2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000902	0.00233	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000901	0.00233	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000888	0.00229	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000874	0.00226	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000867	0.00224	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000855	0.00221	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000855	0.00221	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—GHRL—metabolic syndrome X	0.000842	0.00217	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—PPARG—metabolic syndrome X	0.000839	0.00216	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000836	0.00216	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000824	0.00213	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL5—metabolic syndrome X	0.00082	0.00212	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000811	0.00209	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CNR1—metabolic syndrome X	0.00081	0.00209	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CNR1—metabolic syndrome X	0.000797	0.00206	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000777	0.002	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—AGT—metabolic syndrome X	0.000773	0.00199	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.000756	0.00195	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00075	0.00194	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000742	0.00192	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000711	0.00184	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00069	0.00178	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—AGT—metabolic syndrome X	0.000686	0.00177	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000681	0.00176	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000679	0.00175	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000673	0.00174	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000666	0.00172	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000655	0.00169	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—GHRL—metabolic syndrome X	0.000646	0.00167	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000644	0.00166	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL2—metabolic syndrome X	0.000636	0.00164	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000632	0.00163	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000628	0.00162	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL5—metabolic syndrome X	0.000618	0.00159	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CNR1—metabolic syndrome X	0.000612	0.00158	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000605	0.00156	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000598	0.00154	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000594	0.00153	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000585	0.00151	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HDAC3—metabolic syndrome X	0.000578	0.00149	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—GHRL—metabolic syndrome X	0.000574	0.00148	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000568	0.00147	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL2—metabolic syndrome X	0.000565	0.00146	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000559	0.00144	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CNR1—metabolic syndrome X	0.000543	0.0014	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000537	0.00139	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—metabolic syndrome X	0.000529	0.00137	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—AGT—metabolic syndrome X	0.000525	0.00136	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000522	0.00135	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—AGT—metabolic syndrome X	0.000517	0.00133	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000517	0.00133	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HDAC3—metabolic syndrome X	0.000513	0.00132	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00051	0.00132	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TRIB3—metabolic syndrome X	0.000503	0.0013	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RBP4—metabolic syndrome X	0.000503	0.0013	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000502	0.00129	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000483	0.00125	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000476	0.00123	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL5—metabolic syndrome X	0.000474	0.00122	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000472	0.00122	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—metabolic syndrome X	0.00047	0.00121	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FMO3—metabolic syndrome X	0.000466	0.0012	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000464	0.0012	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000463	0.0012	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000459	0.00118	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000458	0.00118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000456	0.00118	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00045	0.00116	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RBP4—metabolic syndrome X	0.000447	0.00115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TRIB3—metabolic syndrome X	0.000447	0.00115	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOC3—metabolic syndrome X	0.000446	0.00115	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000439	0.00113	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AGT—metabolic syndrome X	0.000437	0.00113	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000433	0.00112	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000433	0.00112	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000432	0.00111	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000426	0.0011	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL5—metabolic syndrome X	0.000421	0.00109	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000419	0.00108	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000416	0.00107	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	0.000416	0.00107	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	0.000416	0.00107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000409	0.00106	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR2C—metabolic syndrome X	0.000402	0.00104	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AGT—metabolic syndrome X	0.000397	0.00102	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOC3—metabolic syndrome X	0.000396	0.00102	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000393	0.00101	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	0.000391	0.00101	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CYBA—metabolic syndrome X	0.00039	0.00101	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AGT—metabolic syndrome X	0.000388	0.001	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000386	0.000997	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GHRL—metabolic syndrome X	0.000382	0.000985	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CNR1—metabolic syndrome X	0.000361	0.000932	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—metabolic syndrome X	0.00036	0.000928	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR2C—metabolic syndrome X	0.000357	0.000923	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000355	0.000916	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AGT—metabolic syndrome X	0.000352	0.000909	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000351	0.000906	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000349	0.000901	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CYBA—metabolic syndrome X	0.000346	0.000894	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000345	0.000892	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000342	0.000883	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RBP4—metabolic syndrome X	0.000342	0.000883	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GHRL—metabolic syndrome X	0.000339	0.000875	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000337	0.000869	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RBP4—metabolic syndrome X	0.000337	0.000869	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000335	0.000865	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FABP4—metabolic syndrome X	0.000332	0.000857	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL2—metabolic syndrome X	0.000327	0.000843	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000322	0.000832	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000321	0.000828	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CNR1—metabolic syndrome X	0.000321	0.000828	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000317	0.000818	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000316	0.000815	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	0.000315	0.000813	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOC3—metabolic syndrome X	0.000303	0.000782	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOC3—metabolic syndrome X	0.000298	0.00077	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000297	0.000766	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF2—metabolic syndrome X	0.000295	0.000762	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000292	0.000754	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL2—metabolic syndrome X	0.00029	0.000749	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOB—metabolic syndrome X	0.000287	0.00074	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000281	0.000724	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL5—metabolic syndrome X	0.00028	0.000723	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000279	0.00072	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.000274	0.000707	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LPL—metabolic syndrome X	0.000274	0.000707	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000274	0.000706	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AGT—metabolic syndrome X	0.00027	0.000696	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000269	0.000695	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000268	0.000691	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000268	0.000691	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGT—metabolic syndrome X	0.000265	0.000684	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CYBA—metabolic syndrome X	0.000265	0.000684	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF2—metabolic syndrome X	0.000262	0.000677	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000261	0.000673	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.000259	0.000669	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GHRL—metabolic syndrome X	0.000259	0.000669	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.000257	0.000663	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000255	0.000658	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOB—metabolic syndrome X	0.000255	0.000657	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL5—metabolic syndrome X	0.000249	0.000642	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000248	0.000639	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CNR1—metabolic syndrome X	0.000246	0.000634	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LPL—metabolic syndrome X	0.000243	0.000628	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000242	0.000624	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.000239	0.000616	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGT—metabolic syndrome X	0.000234	0.000605	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LEP—metabolic syndrome X	0.00023	0.000592	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOE—metabolic syndrome X	0.00023	0.000592	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOA1—metabolic syndrome X	0.000227	0.000586	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000222	0.000573	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000218	0.000564	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	0.000214	0.000553	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LIPC—metabolic syndrome X	0.000213	0.000549	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCK—metabolic syndrome X	0.000213	0.000549	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOC3—metabolic syndrome X	0.000211	0.000546	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGT—metabolic syndrome X	0.000208	0.000537	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CETP—metabolic syndrome X	0.000205	0.00053	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IRS1—metabolic syndrome X	0.000205	0.000528	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LEP—metabolic syndrome X	0.000204	0.000526	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOE—metabolic syndrome X	0.000204	0.000526	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOA1—metabolic syndrome X	0.000202	0.00052	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	0.000201	0.000518	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000198	0.00051	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	0.000197	0.000507	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INS—metabolic syndrome X	0.000196	0.000506	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOB—metabolic syndrome X	0.000195	0.000503	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL2—metabolic syndrome X	0.000193	0.000498	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	0.000192	0.000495	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	0.000191	0.000492	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	0.00019	0.000491	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1—metabolic syndrome X	0.00019	0.000489	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00019	0.000489	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	0.000187	0.000483	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000187	0.000481	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LPL—metabolic syndrome X	0.000186	0.00048	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	0.000186	0.000479	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GOT2—metabolic syndrome X	0.000186	0.000479	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	0.000183	0.000473	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IRS1—metabolic syndrome X	0.000182	0.000469	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00018	0.000465	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INS—metabolic syndrome X	0.000174	0.000449	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NOS3—metabolic syndrome X	0.000172	0.000444	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL2—metabolic syndrome X	0.000171	0.000442	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—metabolic syndrome X	0.000168	0.000435	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	0.000165	0.000427	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	0.000165	0.000427	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GOT1—metabolic syndrome X	0.00016	0.000414	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GGT1—metabolic syndrome X	0.00016	0.000414	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00016	0.000413	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGT—metabolic syndrome X	0.000159	0.000411	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	0.000157	0.000404	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—metabolic syndrome X	0.000156	0.000403	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOE—metabolic syndrome X	0.000156	0.000403	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	0.000154	0.000398	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	0.000153	0.000396	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	0.000153	0.000396	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	0.000153	0.000394	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	0.000152	0.000392	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000147	0.00038	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	0.000145	0.000374	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	0.000139	0.000359	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	0.000137	0.000353	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOB—metabolic syndrome X	0.000136	0.000351	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	0.000134	0.000345	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INS—metabolic syndrome X	0.000133	0.000344	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	0.000132	0.000341	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INS—metabolic syndrome X	0.000131	0.000338	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	0.000131	0.000338	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000131	0.000338	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPL—metabolic syndrome X	0.00013	0.000335	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	0.000129	0.000333	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	0.000129	0.000333	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	0.000129	0.000332	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	0.000127	0.000327	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD36—metabolic syndrome X	0.000123	0.000318	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000122	0.000316	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00012	0.000311	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	0.000119	0.000307	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	0.000117	0.000302	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	0.000115	0.000297	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARA—metabolic syndrome X	0.000115	0.000296	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	0.000114	0.000293	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AGT—metabolic syndrome X	0.000111	0.000287	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOE—metabolic syndrome X	0.000109	0.000281	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA1—metabolic syndrome X	0.000108	0.000278	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	0.000101	0.000261	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	0.0001	0.000258	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	9.86e-05	0.000254	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.85e-05	0.000254	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	9.7e-05	0.00025	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARG—metabolic syndrome X	9.48e-05	0.000245	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—INS—metabolic syndrome X	9.3e-05	0.00024	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	9.09e-05	0.000235	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.95e-05	0.000231	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—metabolic syndrome X	8.57e-05	0.000221	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—metabolic syndrome X	8.52e-05	0.00022	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NOS3—metabolic syndrome X	8.15e-05	0.00021	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	7.9e-05	0.000204	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	7.73e-05	0.000199	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—metabolic syndrome X	7.61e-05	0.000196	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	7.6e-05	0.000196	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	7.46e-05	0.000192	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	7.02e-05	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.82e-05	0.00015	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	5.73e-05	0.000148	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	5.37e-05	0.000139	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	5.29e-05	0.000136	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.75e-05	9.67e-05	CbGpPWpGaD
